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Alzheimer’s disease (AD), a common neurodegenerative disease, is characterized by low levels in the 
brain of the neurotransmitter, acetylcholine (ACh). Clinical treatment of this disease is palliative and 
relies mostly on enhancing cholinergic function by stimulation of cholinergic receptors or prolonging 
the availability of ACh released into the neuronal synaptic cleft by use of agents which restore or 
improve the levels of acetylcholine. Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase 
(BChE), enzymes which breakdown acetylcholine, are considered as a promising strategy for the 
treatment of AD. A potential source of AChE and BChE inhibitors is provided by the abundance of 
plants in nature, and natural products continue to provide useful drugs and templates for the 
development of other compounds. The present work constitutes a review of the literature on 123 
species of medicinal plants that have been tested for AChE inhibitory activity and 42 plant species 
which have been tested for BChE inhibitory activity. The plant species listed are potential 
cholinesterase inhibitors and may aid researchers in their study of natural products which may be 
useful in the treatment of AD. 
 






Neurodegenerative disease is a term applied to a variety 
of conditions arising from a chronic breakdown and 
deterioration of the neurons, particularly those of the 
central nervous system (Houghton and Howes, 2005). 
Alzheimer’s disease (AD) was first described in 1906 by a 
Bavarian neuropsychiatrist Alois Alzheimer (Hostettmann 
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neurodegenerative disease primarily affecting the elderly 
population and is estimated to account for 50 - 60% of 
dementia cases in persons over 65 years of age (Frank 
and Gupta, 2005). The pathological features identified in 
the central nervous system (CNS) in AD are amyloid 
plaques, neurofibrillary tangles, inflammatory processes 
and disturbance of neurotransmitters (Selkoe, 2001; 
Bossy-Wetzel et al., 2004). There is also a progressive 
loss of neurons in the basal forebrain, which is the major 
source of cholinergic innervations of the neocortex and 
hippocampus. These changes involve progressive and 
irreversible impairment of cognitive function, resulting 
mainly in a loss of memory, with neurological and 
neuropsychiatric disorders (Hostettmann et al., 2006). 
The pathophysiology of AD is complex and involves 
several different biochemical pathways. The first neuro-
transmitter defect discovered in AD involved acetyl-
choline (ACh), which plays an important role in memory 
and learning. In the CNS, ACh stimulation of the nicotinic 
receptors  appears   to   be   associated    with    cognitive  




function. Normally, ACh is stored in the nerve terminals, 
in structures called vesicles and is released from the 
nerve endings when the nerve terminal is depolarized, 
thereby entering the synapse and binding to the receptor 
(Houghton et al., 2006). However, in patients with AD, the 
ACh which is released has a very short half-life due to the 
presence of large amounts of the enzymes; acetylcholi-
nesterase (AChE) and butyrylcholinesterase (BChE), 
which are both present in the brain and are detected 
among neurofibrillary tangles and neuritic plaques (Beard 
et al., 1995; Orhan et al., 2004). These enzymes 
hydrolyse the ester bond in the ACh molecule, leading to 
loss of stimulatory activity.  
The increase in life expectancy during the 20th century 
has concomitantly increased the number of people 
suffering from the disease. There are considerable 
financial, social and emotional burdens associated with 
the caring for patients with this disease (Akhondzadeh 
and Noroozian, 2002). In fact, in advanced industrialized 
and post-industrialized societies, where life expectancy is 
long, this disease is a major cause of morbidity and it 
imposes severe strains on the social welfare systems. It 
is estimated that in the USA, at least 5 million people are 
affected by AD (Houghton and Howes, 2005).  
Approaches to enhance cholinergic function in AD have 
included stimulation of cholinergic receptors or prolonging 
the availability of ACh released into the neuronal synaptic 
cleft by use of agents which restore the level of 
acetylcholine through inhibition of both AChE and BChE. 
BChE, primarily associated with glial cells and specific 
neuronal pathways cleaves ACh in a similar manner to 
AChE to terminate its physiological action.  Such studies, 
together with a statistically slower decline in the cognitive 
performance of dementia patients possessing specific 
BChE polymorphisms that naturally lower BChE activity, 
have targeted BChE as a new approach to intercede in 
the progression of AD (Loizzo et al., 2009). Recently, 
Hodges (2006) demonstrated that the inhibition of AChE 
holds a key role not only to enhance cholinergic trans-
mission in the brain but also to reduce the aggregation of 
β-amyloid and the formation of the neurotoxic fibrils in 
AD. Therefore, AChE and BChE inhibitors have become 
remarkable alternatives in treatment of AD (Orhan et al., 
2004). Existing anticholinesterase drugs (example, 
tacrine, donepezil, physostigmine, galantamine and 
heptylphysostigmine) for the treatment of dementia are 
reported to have several dangerous adverse effects such 
as hepatotoxicity, short duration of biological action, low 
bioavailability, adverse cholinergic side effects in the 
periphery and a narrow therapeutic window (Hung et al., 
2008; Sancheti et al., 2009). 
The history of drug discovery has shown that plants 
contain active compounds that have become new sources 
to investigate for the pharmaceutical industry. Plant 
constituents may not only act synergistically with other 
constituents from the same plant but may also enhance 





compounds from other plant species (Howes and 
Houghton, 2003). In traditional practices, numerous 
plants have been used to treat cognitive disorders, 
including neurodegenerative diseases and different 
neuropharmacological disorders (Mukherjee et al., 
2007a). Yokukansan, a Chinese herbal remedy which is 
used to treat various neurological states has been 
reported as being effective with no adverse effects (De 
Caires and Steenkamp, 2010).  Also, galanthamine, an 
alkaloid from snowdrop, has been approved by the Food 
and Drug Administration in the United States for use in 
the treatment of Alzheimer’s disease (Ingkaninan et al., 
2003; Heinrich and Teoh, 2004). Since AD has become a 
public health burden, and the commonly available syn-
thetic drugs have undesirable side-effects, new treatment 
strategies based on medicinal plants have been the 
subject of current focus. This article summarizes the 






The colorimetric method of Ellman et al. (1961) which is 
based on determining the amount of thiocholine released 
when acetylthiocholine or butyrylthiocholine is hydrolysed 
by AChE or BChE is widely used. The thiocholine released 
is quantified by its reaction with 5,5´-bisdithionitrobenzoic 
acid (DTNB), which produces a yellow 5-thio-2-nitro-
benzoate anion. Several 96-well microplate assays have 
been derived from Ellman’s method with some 
modifications which have enabled determinations to be 
performed with a much higher throughput (Houghton et 
al., 2006). 
The Ellman reaction for detecting AChE and BChE 
inhibitory activity has also been adapted for thin layer 
chromatography (TLC) plates. Samples are spotted on 
the plate before standard development, after which a 
solution of DTNB and acetylthiocholine iodide (ATCI) or 
butyrylthiocholine chloride (BTCCl) is sprayed until the 
plate is saturated. Thereafter the enzyme solution is 
sprayed on the plate and it is incubated for 5 min. A 
yellow coloration with white spots is indicative of inhibi-
tory activity. This provides an extremely rapid method to 
screen large numbers of samples to discover new 
inhibitors of AChE and BChE (Hostettmann et al., 2006). 
However, this method is known to give a number of false-
positive effects. To rule out such results, plates are first 
sprayed with DTNB, followed by a mixture of the enzyme 
and ATCI where the occurrence of white spots is 
indicative of false positive results (Adsersen et al., 2006; 
Houghton et al., 2006). A similar method for TLC 
detection has been introduced which uses acetylnaphthol 
as the substrate and measures the amount of naphthol, 
the reaction product formed, by its chromogenic reaction 
with Fast Blue B salt (Giovanni et al., 2008). 





quantification of AChE and BChE inhibition include high 
performance liquid chromatography (HPLC) with on-line 
coupled UV-MS-biochemical detection (Ingkaninan et al., 
2000), fluorometry, radiometric assay, mass spectrometry, 
and assays based on immobilized enzyme (Hostettmann 
et al., 2006). Fluorometric methods are reported to be 
more sensitive than colorimetric methods for the assay of 
AChE and BChE. Fluorogenic substrates such as 2-
naphthyl acetate, indoxyl acetate, resorufin butyrate and 
fluorofore coumarinylphenylmaleimide have been utilized 
(Rhee et al., 2003). A limitation of the flow assay could be 
that the presence in the plant extract of fluorescent com-
pounds with similar excitation and emission wavelengths 
as the product of the enzyme reaction results in a positive 
peak which might obscure inhibitory activity. 
 
 
CHOLINESTERASE INHIBITORY ACTIVITY OF PLANT 
EXTRACTS  
 
Acetylcholinesterase inhibitory activity 
 
Extracts of several medicinal plants have been reported 
to show AChE inhibitory activity. A summary of screening 
studies of these plants is provided in Table 1 in alpha-
betical order of their family, together with their scientific 
names, plant part, solvent extract, percentage inhibition 
and concentration at which the enzyme is inhibited. 
Aqueous and methanol extracts of 11 plants, used in 
Danish folk medicine for improvement of memory and 
cognition, and three Corydalis species have been tested 
for their AChE inhibitory activity (Adsersen et al., 2006). 
The authors reported significant dose-dependent inhibi-
tory activity for extracts of the Corydalis species whereas 
only moderate inhibition of the enzyme was observed for 
extracts of Ruta graveolens L., Lavandula augustifolia 
Miller, Rosmarinus officinalis L., Petroselinum crispum 
(Mil.) Nym. ex A. W. Hill., and Mentha spicata L. The 
latter five species contain essential oils with terpenes, a 
group of compounds reported to have AChE inhibitory 
activity (Perry et al., 2000; Adsersen et al., 2006). 
Ferreira et al. (2006) reported the AChE inhibitory 
activity of the essential oil, ethanol extract and decoction 
of ten plant species from Portugal. Among the plant ex-
tracts screened, Melissa officinalis, Paronychia argentea, 
Sanguisorba minor, Hypericum undulatum and Malva 
silvestris are used in herbal medicine, Laurus nobilis and 
Mentha suaveolens as condiments, and Lavandula 
augustifolia and Lavandula pedunculata as aromatics. M. 
officinalis and M. suaveolens showed AChE inhibitory 
capacity higher than 50% in the essential oil fraction. The 
ethanol extract of L. nobilis, H. undulatum and S. minor 
exhibited AChE inhibition of 64% (1 mg/ml), 68% (0.5 
mg/ml) and 78% (1 mg/ml), respectively. In addition 
decoctions of L. pedunculata, M. suaveolens and H. 
undulatum at 5 mg/ml, exhibited percentage inhibitions of 
68, 69 and 82%, respectively.  




Mukherjee et al. (2007b) reported the AChE inhibitory 
activity of the hydroalcohol extracts of six herbs used in 
Indian system of medicine. The hydroalcohol extract from 
Centella asiatica, Nardostachys jatamansi, Myristica 
fragrans, Evalvulus alsinoides inhibited 50% of AChE 
activity (IC50) at concentrations of 100 - 150 µg/ml.  The 
AChE inhibitory activity of petroleum ether, chloroform, 
ethyl acetate and methanol extracts obtained from 14 
Salvia species growing in Turkey has been reported 
(Orhan et al., 2007). Most of the extracts did not show 
any activity against AChE at 0.2 mg/ml. The most active 
extracts at 1 mg/ml for AChE inhibition were the 
petroleum ether extract of S. albimaculata (89.4%) and 
chloroform extract of S. cyanescens (80.2%). In a recent 
study by Khadri et al. (2010), the aqueous extract, 
proanthocyanidin rich extract and organic extracts of 
Cymbopogon schoenanthus shoots from South Tunisia 
all showed good AChE inhibitory activity. 
 
 
Butyrylcholinesterase inhibitory activity 
 
BChE has been shown to be implicated in the pro-
gression of AD as it also reduces the availability of ACh 
which is an important neurotransmitter in AD. A summary 
of medicinal plants which have been screened and 
reported to have BChE inhibitory activity are listed in 
Table 1. 
The chloroform: methanol (1:1) extracts of 21 plant 
species were screened for their anticholinesterase 
activity on BChE enzyme by the in vitro method of Ellman 
(Orhan et al., 2004). The extracts did not show any 
noticeable inhibitory activity against the enzyme at 10 
µg/ml, however, extracts of Rhododendron ponticum 
subsp. ponticum, Corydalis solida subsp. solida and 
Buxus semperivirens showed inhibition at 1 mg/ml. 
Loizzo et al. (2009) evaluated the essential oils of 
Origanum ehrenbergii and Origanum syriacum both 
collected from Lebanon for their BChE inhibitory activity 
when using a modification of Ellman’s method, with O. 
ehrenbergii showing the highest activity. The data 
obtained from this and other studies on both oils showed 
that they could be used as a valuable new flavor with 
functional properties for food or nutriceutical products 
with particular relevance to supplements for the elderly. 
Petroleum ether, chloroform, ethyl acetate and 
methanol extracts of 14 Salvia species have also been 
screened for possible BChE inhibitory activity. At 1 
mg/ml, the ethyl acetate extracts of Salvia frigida and 
Salvia migrostegia, chloroform extracts of Salvia 
candidissima ssp. occidentalis and Salvia ceratophylla, 
as well as petroleum ether extract of Salvia cyanescens 





Inhibition of AChE, the key enzyme in  the  breakdown  of 




Table 1.  Medicinal Plants with cholinesterase inhibitory activity 
 
Family and botanical 
name 




Method; Activity (% 
inhibition) (concentration 
of plant extract tested) 
BChE 
Method; Activity (% inhibition) 
(concentration of plant 
 extract tested) 
References 
Acanthaceae      
Acanthus ebracteatus 
Vahl. 
Aerial part Methanol TLC and 96 well plate;  
36.19 ± 8.00 (0.1mg/ml) 
ND Ingkaninan et al. (2003); 





96 well plate;                   
50% (222.41µg/ml)* 
ND Mukherjee et al. (2007b) 
Anacardiaceae      
Magnifera indica L. 
 
Bark Methanol TLC and 96 well plate;     
8.15 ± 0.77 (100 µg/ml) 
ND Vinutha et al. (2007) 
 Bark Water TLC and 96 well plate; 
6.29 ± 0.37 (100µg/ml) 





TLC and 96 well plate; 
69.94 ± 0.75 (100 µg/ml) 
ND Vinutha et al. (2007) 
 Bark Water TLC and 96 well plate; 
1.09 ± 0.37 (100 µg/ml) 
ND Vinutha et al. (2007) 
Apiaceae      
Carum carvi L. Radix Methanol TLC and 96 well plate;  
11.00 ± 0.00   (0.1mg/ml) 
ND Adsersen et al. (2006) 
Petroselinum crispum 
(Mil.) Nym. ex A. W. Hill. 
Radix Methanol TLC and 96 well plate;  
21.00 ± 0.00 (0.1mg/ml) 
ND Adsersen et al. (2006) 
Pimpinella anisum L. Fructus Methanol TLC and 96 well plate; 
3.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
Apocynaceae      
Tabernaemontana 
divaricata L. 








Chattipakorn et al. (2007) 
Araceae      




ND Ahmed et al. (2009) 
Asteraceae      
Carthamus tinctorius L. Flower Methanol TLC and 96 well plate;  
30.33 ± 9.22 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Brassicaceae      
Capsella bursa-pastoris 
(L.) Medik. 
Whole plant Methanol 96 well plate; 
10.00 ± 2.00 (5 mg/ml) 
96 well plate; 
13.00 ± 1.00 (5 mg/ml) 
Sancheti et al. (2009) 




Table 1. Cont’d 
 
Buxaceae      
Buxus sempervirens L. Whole plant Chloroform: methanol 
(1:1) 
96 well plate; 
61.76 ± 0.76 (1 mg/ml) 
ND Orhan et al. (2004); 
Mukherjee et al. (2007 a) 
Caesalpinaceae      
Robinia pseudoacacia L. Whole plant Chloroform: methanol 
(1:1) 
96 well plate; 
26.32 ± 0.82 (1 mg/ml) 
96 well plate; 
31.47 ± 0.99 (1mg/ml) 
Orhan et al. (2004) 
Caryophyllaceae      




UV spectophotometry;  
26.10 ± 1.20 (5 mg/ml) 
ND Ferreira et al. (2006) 
 Aerial parts Essential oil UV spectophotometry;  
49.50 ± 1.00 (1 mg/ml) 
ND Ferreira et al. (2006) 
 
 Aerial parts Ethanol UV spectophotometry;  
48.70 ± 6.10 (0.5 mg/ml) 
ND Ferreira et al. (2006) 
 
Celastraceae      
Euonymus sachalinensis (F. 
Schmidt.) Maxim. 
Leaf Methanol 96 well plate; 
10.00 ± 3.00 (5 mg/ml) 
96 well plate; 
43.00 ± 1.00 (5 mg/ml) 
Sancheti et al. (2009) 
Combretaceae      
Combretum kraussii Hochst. Leaf Ethyl acetate TLC and 96 well plate;  
96.00 ± 4.60 (1 mg/ml) 
ND Eldeen et al. (2005) 
 Leaf Ethanol TLC and 96 well plate;  
88.00 ± 3.10 (1 mg/ml) 
ND Eldeen et al. (2005) 
 Bark Ethyl acetate TLC and 96 well plate;  
82.00 ± 6.10 (1 mg/ml) 
ND Eldeen et al. (2005) 
 Bark Ethanol TLC and 96 well plate;  
83.00 ± 4.50(1 mg/ml) 
ND Eldeen et al. (2005) 
 Root Ethyl acetate TLC and 96 well plate;  
81.00 ± 4.10 (1 mg/ml) 
ND Eldeen et al. (2005) 
 Root Ethanol TLC and 96 well plate;  
82.00 ± 5.20 (1 mg/ml) 
ND Eldeen et al. (2005) 
Terminalia bellirica (Gaertn.) 
Roxb. 
Fruit Methanol TLC and 96 well plate;  
39.68 ± 8.15 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007a) 
Terminalia chebula Retz. Fruit Methanol 96 well plate;  
89.00 ± 1.00 (5 mg/ml) 
96 well plate; 
95.00 ± 1.00 (5 mg/ml) 
Sancheti et al. (2009) 
Convolvulaceae      
Convolvulus pluricaulis Choisy. Whole plant Methanol TLC and 96 well plate;  
2.22 ± 1.17 (100 µg/ml) 
ND Vinutha et al. (2007) 
Evalvulus alsinoides L. Whole plant Hydro alcohol 96 well plate;  
50% (141.76 µg/ml)* 
ND Mukherjee et al. (2007 b) 




Table 1. Cont’d 
 
Crassulaceae      
Rhodiola rosea L. Root Methanol 96 well plate;  
42.00 ± 3.20 (10 g/l) 
ND Hillhouse et al. (2004); 
Mukherjee et al. (2007 a) 
Cupressaceae      
Chamaecyparis pisifera 
(Siebold and Zuccarini) 
Endlicher 
Whole plant Methanol 96 well plate;  
59.00 ± 2.00 (5 mg/ml) 
96 well plate; 
62.00 ± 2.00 (5 mg/ml) 
Sancheti et al. (2009) 
Cyperaceae      
Cyperus rotundus L. Whole plant Methanol TLC and 96 well plate;  
44.19 ± 2.27 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Dioscoreaceae      
Dioscorea bulbifera L. Whole plant Methanol 96 well plate;  
79.00 ± 2.00 (5 mg/ml) 
96 well plate; 
82.00 ± 2.00 (5 mg/ml) 
Sancheti et al. (2009) 
Ericaceae      
Rhododendron luteum Sweet. Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
76.32 ± 0.58 (1 mg/ml) 
96 well plate; 
69.14 ± 1.89 (1 mg/ml) 
Orhan et al. (2004); 
Mukherjee et al. (2007 a) 
Rhododendron ponticum L. 
subsp. Ponticum 
Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
93.03 ± 1.12 (1 mg/ml) 
96 well plate; 
95.23 ± 1.28 (1 mg/ml) 
Orhan et al. (2004); 
Mukherjee et al. (2007 a) 
Rhododendron 
schlippenbachii Maxim. 
Whole plant Methanol 96 well plate;  
67.00 ± 1.00 (5 mg/ml) 
96 well plate; 
63.00 ± 2.00 (5 mg/ml) 
Sancheti et al. (2009) 
Euphorbiaceae      
Euphorbia antiquorum L. Stem Methanol TLC and 96 well plate;  
42.31 ± 9.10 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Fabaceae      
Albizia adianthifolia 
(Schumach.) W.F. Wight. 
Bark Ethyl acetate TLC and 96 well plate;  
61.00 ± 5.10 (1 mg/ml) 
ND Eldeen et al. (2005) 
 Bark Ethanol TLC and 96 well plate;  
53.00 ± 2.20 (1 mg/ml) 
ND Eldeen et al. (2005) 
 Root Ethyl acetate TLC and 96 well plate;  
45.00 ± 2.10 (1 mg/ml) 
ND Eldeen et al. (2005) 
 Root Ethanol TLC and 96 well plate;  
51.00 ± 3.40 (1 mg/ml) 
ND Eldeen et al. (2005) 
Vicia faba L. Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
45.23 ± 1.03 (1 mg/ml) 
96 well plate; 
55.85 ± 0.48 (1 mg/ml) 
Orhan et al. (2004); 
Mukherjee et al. (2007 a) 




Table 1. Cont’d 
 
Fumariaceae      
Fumaria asepala Boiss. Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
91.99 ± 0.70 (1 mg/ml) 
96 well plate; 
93.12 ± 0.28 (1 mg/ml) 
Orhan et al. (2004); Mukherjee et 
al. (2007 a) 
Fumaria capreolata L. Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
96.89 ± 0.17 (1 mg/ml) 
96 well plate; 
89.24 ± 0.83 (1 mg/ml) 
Orhan et al. (2004); Mukherjee et 
al. (2007 a) 
Fumaria cilicica Hausskn. Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
88.03 ± 0.65 (1 mg/ml) 
96 well plate; 
80.03 ± 0.28 (1 mg/ml) 
Orhan et al. (2004); Mukherjee et 
al. (2007 a) 
Fumaria densiflora DC. Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
93.42 ± 0.92 (1 mg/ml) 
96 well plate; 
85.66 ± 1.24 (1 mg/ml) 
Orhan et al. (2004); Mukherjee et 
al. (2007 a) 
Fumaria flabellata L. Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
92.14 ± 1.01 (1 mg/ml) 
96 well plate; 
87.91 ± 0.61 (1 mg/ml) 
Orhan et al. (2004); Mukherjee et 
al. (2007 a) 
Fumaria judaica Boiss. Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
96.47 ± 0.63 (1 mg/ml) 
96 well plate; 
98.43 ± 0.39 (1 mg/ml) 
Orhan et al. (2004); Mukherjee et 
al. (2007 a) 
Fumaria kralikii Jordan Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
84.98 ± 1.07 (1 mg/ml) 
96 well plate; 
75.43 ± 0.98 (1 mg/ml) 
Orhan et al. (2004); Mukherjee et 
al. (2007 a) 
Fumaria macrocarpa Boiss. 
ex Hausskn. 
Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
93.43 ± 0.64 (1 mg/ml) 
96 well plate; 
88.74 ± 0.34 (1 mg/ml) 
Orhan et al. (2004); Mukherjee et 
al. (2007 a) 
Fumaria parviflora Lam. Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
87.02 ± 0.31 (1 mg/ml) 
96 well plate; 
87.09 ± 1.45 (1 mg/ml) 
Orhan et al. (2004); Mukherjee et 
al. (2007 a) 
Fumaria petteri Reichb subsp. 
thuretii (Boiss.) 
Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
89.45 ± 0.86 (1 mg/ml) 
96 well plate; 
87.32 ± 0.76 (1 mg/ml) 
Orhan et al. (2004); Mukherjee et 
al. (2007 a) 
Fumaria vaillantii Lois. 
 
Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
94.23 ± 0.47 (1 mg/ml) 
96 well plate; 
99.32 ± 0.25 (1 mg/ml) 
Orhan et al. (2004); Mukherjee et 
al. (2007 a) 
Ginkgoaceae      
Ginkgo biloba L. Whole plant Ethanol 96 well plate;  
50% (268.33 µg)* 
ND Perry et al. (1998); Das et al. 
(2002); Mukherjee et al. (2007 a) 
Guttiferae      
Mammea harmandii Kosterm. Flower Methanol TLC and 96 well plate;  
33.63 ± 8.00 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Hypericaceae      
Hypericum undulatum 
Shoubs. ex Willd. 
Flower Water UV spectophotometry; 
81.70 ± 3.40 (5 mg/ml)
 
ND Ferreira et al. (2006) 
 Flower Essential oil UV spectophotometry; 
30.30 ± 19.70 (1 mg/ml)
 
ND Ferreira et al. (2006) 
 Flower Ethanol UV spectophotometry; 
68.40 ± 4.70 (0.5 mg/ml)
 
ND Ferreira et al. (2006) 




Table 1. Cont’d 
 
Lamiaceae      




TLC and 96 well plate;  
34.00 ± 0.00 (0.1 mg/ml) 
ND Ferreira et al. (2006) 
 
 Aerial parts Essential oil UV spectophotometry; 
39.50 ± 8.60 (1 mg/ml) 
ND Ferreira et al. (2006) 
 
 Aerial parts Ethanol UV spectophotometry; 
64.30 ± 9.00 (1 mg/ml) 









67.80 ± 10.70 (5 mg/ml) 
ND Ferreira et al. (2006) 
 
 Aerial parts Essential oil UV spectophotometry; 
56.50 ± 4.90 (0.5 mg/ml) 
ND Ferreira et al. (2006) 
 
 Aerial parts Ethanol UV spectophotometry; 
42.00 ± 16.80 (1 mg/ml) 
ND Ferreira et al. (2006) 
 
Mentha spicata L. 
 









TLC and 96 well plate;  
15.00 ± 0.00 (0.1 mg/ml) 
UV spectophotometry; 




Adsersen et al. (2006) 
Ferreira et al. (2006) 
 
 Aerial parts Essential oil UV spectophotometry; 
52.40 ± 2.50 (1 mg/ml) 




Aerial parts Ethanol UV spectophotometry; 
27.10 ± 2.70 (1 mg/ml) 
ND Ferreira et al. (2006) 
 
Origanum vulgare L. Whole plant 
 
Methanol TLC and 96 well plate;  
3.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
 
Origanum ehrenbergii Boiss 
 














50% (1.7 µg/ml)* 
UV spectophotometry; 
50% (0.3 µg/ml)* 
UV spectophotometry; 
50% (1.6 µg/ml)* 
Loizzo et al. (2009) 
 
Loizzo et al. (2009) 
 
Rosmarinus officinalis L. Whole plant 
 
Methanol TLC and 96 well plate;  
17.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
Salvia albimaculata Hedge 
and Hub 
Whole plant Petroleum ether 96 well plate;  
89.40 ± 2.07 (1 mg/ml) 
96 well plate; 
73.90 ± 0.76 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Chloroform NI 96 well plate; 
87.90 ± 0.22 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Ethyl acetate 96 well plate;  
51.70 ± 3.22 (1 mg/ml) 
96 well plate; 
69.80 ± 1.99 (1 mg/ml) 
Orhan et al. (2007) 




Table 1. Cont’d 
 
 Whole plant Methanol 96 well plate;  
38.90 ± 3.22 (1 mg/ml) 
96 well plate; 
27.40 ± 1.32 (1 mg/ml) 
Orhan et al. (2007) 
Salvia aucheri Bentham var. 
canescens Boiss and Heldr 
Whole plant Chloroform 96 well plate;  
64.50 ± 1.03 (1 mg/ml) 
96 well plate; 
77.60 ± 3.76 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Ethyl acetate 96 well plate;  
53.40 ± 1.59 (1 mg/ml) 
96 well plate; 
69.60 ± 2.15 (1mg/ml) 
Orhan et al. (2007) 
 Whole plant Methanol 96 well plate;  
39.90 ± 1.17 (1 mg/ml) 
96 well plate; 
12.60 ± 1.05 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Petroleum ether 96 well plate;  
27.30 ± 0.98 (1 mg/ml) 
96 well plate; 
59.90 ± 378.00 (1 
mg/ml) 
Orhan et al. (2007) 
Salvia candidissima Vahl. ssp. 
occidentalis 
Whole plant Chloroform 96 well plate;  
48.60 ± 5.13 (1 mg/ml) 
96 well plate; 
91.10 ± 1.98 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Ethyl acetate 96 well plate;  
46.10 ± 1.28 (1 mg/ml) 
96 well plate; 
77.80 ± 0.93 (1 mg/ml) 
Orhan et al. (2007) 
 
 Whole plant Petroleum ether 96 well plate;  
39.40 ± 4.31 (1 mg/ml) 
96 well plate; 
55.60 ± 0.28 (1 mg/ml) 
Orhan et al. (2007) 
Salvia ceratophylla L. Whole plant Chloroform 96 well plate;  
30.80 ± 5.25 (1 mg/ml) 
96 well plate; 
91.10 ± 1.98 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Ethyl acetate 96 well plate;  
19.30 ± 1.57 (1 mg/ml) 
96 well plate; 
29.20 ± 0.77 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Methanol 96 well plate;  
27.80 ± 2.82 (1 mg/ml) 
96 well plate; 
34.90 ± 6.50 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Petroleum ether NI 96 well plate; 
38.80 ± 4.94 (1 mg/ml) 
Orhan et al. (2007) 
Salvia cryptantha Montbret 
and Bentham 
Whole plant Chloroform 96 well plate;  
24.90 ± 1.65 (1 mg/ml) 
NI 
 
Orhan et al. (2007) 
 Whole plant Ethyl acetate 96 well plate;  
73.30 ± 2.55 (1 mg/ml) 
96 well plate; 
53.60 ± 0.67 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Methanol 96 well plate;  
47.20 ± 5.18 (1 mg/ml) 
96 well plate; 
36.30 ± 2.79 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Petroleum ether 96 well plate;  
71.80 ± 2.62 (1 mg/ml) 
96 well plate; 
92.00 ± 0.41 (1mg/ml) 
Orhan et al. (2007) 
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Salvia cyanescens Boiss and 
Bal. 
Whole plant Chloroform 96 well plate;  
80.20 ± 4.35 (1 mg/ml) 
96 well plate; 
91.80 ± 0.54 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Ethyl acetate 96 well plate;  
51.20 ± 3.78 (1 mg/ml) 
96 well plate; 
56.90 ± 1.03 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant 
 
Methanol 96 well plate;  
9.00 ± 0.88 (1 mg/ml) 
96 well plate; 
13.10 ± 0.70 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Petroleum ether 96 well plate;  
37.70 ± 5.35 (1 mg/ml) 
96 well plate; 
67.40 ± 3.59 (1 mg/ml) 
Orhan et al. (2007) 
Salvia forskahlei L. Whole plant Chloroform 96 well plate;  
41.30 ± 2.91 (1 mg/ml) 
96 well plate; 
60.20 ± 4.42 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Ethyl acetate 96 well plate;  
47.00 ± 2.31 (1 mg/ml) 
96 well plate; 
62.90 ± 0.67 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Methanol 96 well plate;  
35.80 ± 2.46 (1 mg/ml) 
96 well plate; 
46.70 ± 3.69 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Petroleum ether 96 well plate;  
25.20 ± 4.46 (1 mg/ml) 
96 well plate; 
69.30 ± 1.65 (1mg/ml) 
Orhan et al. (2007) 
Salvia frigida Boiss Whole plant Chloroform 96 well plate;  
53.70 ± 2.25 (1 mg/ml) 
96 well plate; 
77.80 ± 0.21 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Ethyl acetate 96 well plate;  
59.50 ± 0.45 (1 mg/ml) 
96 well plate; 
92.20 ± 0.29 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Methanol 96 well plate;  
32.60 ± 0.01 (1 mg/ml) 
96 well plate; 
59.90 ± 2.30 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Petroleum ether 96 well plate;  
6.20 ± 0.24 (1 mg/ml) 
96 well plate; 
54.90 ± 1.95 (1 mg/ml) 
Orhan et al. (2007) 
Salvia halophila Hedge Whole plant Chloroform NI 96 well plate; 
53.90 ± 2.16 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Ethyl acetate 96 well plate;  
36.10 ± 1.21 (1 mg/ml) 
96 well plate; 
37.20 ± 3.88 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Petroleum ether 96 well plate;  
18.90 ± 1.21 (1 mg/ml) 
96 well plate; 
50.90 ± 4.20 (1 mg/ml) 
Orhan et al. (2007) 
Salvia lavandulaefolia Vahl. Whole plant Steam distilled oil 96 well plate;  
63.00 ± 3.70 (0.1 µg/ml) 
ND Perry et al. (1996, 2000, 
2001); Mukherjee et al. 
(2007 a) 
Salvia migrostegia Boiss and 
Bal. 
Whole plant Chloroform 96 well plate;  
36.40 ± 5.45 (1 mg/ml) 
96 well plate; 
62.50 ± 1.31 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Ethyl acetate 96 well plate;  
37.10 ± 3.15 (1 mg/ml) 
96 well plate; 
89.60 ± 0.67 (1 mg/ml) 
Orhan et al. (2007) 
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 Whole plant Methanol 96 well plate;  
23.60 ± 0.61 (1 mg/ml) 
96 well plate; 
32.60 ± 3.40 (1 mg/ml) 
Orhan et al. (2007) 
 
 
Whole plant Petroleum ether NI 96 well plate; 
22.10 ± 2.70 (1 mg/ml) 
Orhan et al. (2007) 
Salvia multicaulis 
Vahl. 
Whole plant Ethyl acetate NI 96 well plate; 
64.30 ± 1.02 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Methanol 96 well plate;  
47.70 ± 3.58 (1 mg/ml) 
96 well plate; 
36.20 ± 0.93 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Petroleum ether 96 well plate;  
21.40 ± 3.91 (1 mg/ml) 
96 well plate; 
68.80 ± 3.80 (1 mg/ml) 
Orhan et al. (2007) 
Salvia officinalis L. Whole plant Ethanol 96 well plate;  
68.20 ± 15.60 (2.5 mg/ml) 
ND Perry et al. (1996, 2000, 
2001); Mukherjee et al. 
(2007 a) 
 Whole plant Steam distilled oil 96 well plate;  
52.40 ± 0.80 (0.1 µg/ml) 
ND Perry et al. (1996, 2000, 
2001); Mukherjee et al. 
(2007 a) 
Salvia sclarea L. Whole plant Chloroform 96 well plate;  
55.30 ± 0.98 (1 mg/ml) 
96 well plate; 
59.90 ± 0.50 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Ethyl acetate 96 well plate;  
33.50 ± 4.94 (1 mg/ml) 
96 well plate; 
75.70 ± 1.83 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Methanol 96 well plate;  
25.30 ± 1.86 (1 mg/ml) 
96 well plate; 
15.10 ± 1.76 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Petroleum ether 96 well plate;  
25.80 ± 4.51 (1 mg/ml) 
96 well plate; 
52.60 ± 2.92 (1 mg/ml) 
Orhan et al. (2007) 
Salvia syriaca L. Whole plant Chloroform 96 well plate;  
66.90 ± 2.49 (1 mg/ml) 
96 well plate; 
87.30 ± 1.99 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Ethyl acetate 96 well plate;  
49.80 ± 2.41 (1 mg/ml) 
96 well plate; 
70.90 ± 2.69 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Methanol 96 well plate;  
12.10 ± 1.22 (1 mg/ml) 
96 well plate; 
12.30 ± 1.10 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Petroleum ether 96 well plate;  
33.40 ± 2.98 (1 mg/ml) 
96 well plate; 
63.50 ± 2.12 (1 mg/ml) 
Orhan et al. (2007) 
Salvia triloba L. Aerial parts Ethanol 96 well plate;  
54.30 ± 3.20 (2 mg/ml) 
ND Orhan et al. (2007) 
 
Salvia verticillata L. 
ssp. amasiaca 
Whole plant Chloroform NI 96 well plate; 
55.70 ± 0.55 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Ethyl acetate NI 96 well plate; 
53.30 ± 5.50 (1 mg/ml) 
Orhan et al. (2007) 




Table 1. Cont’d 
 
 Whole plant Methanol 96 well plate;  
39.10 ± 3.10 (1 mg/ml) 
96 well plate; 
72.00 ± 2.99 (1 mg/ml) 
Orhan et al. (2007) 
 Whole plant Petroleum ether 96 well plate;  
45.60 ± 4.17 (1 mg/ml) 
96 well plate; 
85.00 ± 53.10 (1 mg/ml) 
Orhan et al. (2007) 
Teucrium polium L. Aerial parts Ethanol 96 well plate;  
65.80 ± 3.70 (2 mg/ml) 
ND Orhan et al. (2009) 
Lauraceae      
Laurus nobilis L. Leaf Decoction UV spectophotometry; 
56.10 ± 5.50 (5 mg/ml) 
ND Ferreira et al. (2006) 
 
 Leaf Essential oil UV spectophotometry; 
51.30 ± 1.70 (0.5 mg/ml) 
ND Ferreira et al. (2006) 
 
 Leaf Ethanol UV spectophotometry; 
64.30 ± 9.00 (1 mg/ml) 
ND Ferreira et al. (2006) 
 
Leguminosae      
Albizia procera (Roxb.) 
Benth. 
Bark Methanol TLC and 96 well plate;  
40.71 ± 0.46 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Butea superba Roxb. 
 
Root barks Methanol TLC and 96 well plate;  
55.87 ± 5.83 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Cassia fistula L. Root Methanol TLC and 96 well plate;  
54.13 ± 3.90 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Mimosa pudica L. Whole plant Water TLC and 96 well plate;  
1.68 ± 0.22 (100 µg/ml) 
ND Vinutha et al. (2007) 
Trigonella foenum graecum 
L. 
Seeds Hydro alcohol TLC and 96 well plate;  
50% (140.26 µg)* 
ND SatheeshKumar et al. 
(2009) 
 Seeds Ethyl acetate TLC and 96 well plate;  
50% (53 µg)* 
ND SatheeshKumar et al. 
(2009) 
 Seeds Chloroform TLC and 96 well plate;  
50% (146.94 µg)* 
ND SatheeshKumar et al. 
(2009) 
Lycopodiaceae      
Lycopodium clavatum L. Whole plant Chloroform: methanol 
(1:1) 
96 well plate;  
49.85 ± 1.33 (1 mg/ml) 
ND Orhan et al. (2004); 
Mukherjee et al. (2007 a) 
Magnoliaceae      
Michelia champaca L. Leaf Methanol TLC and 96 well plate;  
34.88 ± 4.56 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Malvaceae      
Abutilon indicum L. Whole plant Methanol TLC and 96 well plate;  
30.66 ± 1.06 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
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Malva silvestris L. Aerial parts Aqueous UV spectophotometry; 
25.00 ± 5.70 (5 mg/ml) 
ND Ferreira et al. (2006) 
 
 Aerial parts Essential oil UV spectophotometry; 
28.10 ± 2.90 (0.1 mg/ml) 
ND Ferreira et al. (2006) 
 
Meliaceae      




TLC and 96 well plate;  
5.89 ± 0.33 (100 µg/ml) 
ND Vinutha et al. (2007) 
 
Trichilia dregeana Sond. Bark Ethyl acetate TLC and 96 well plate;  
55.00 ± 4.40 (1 mg/ml) 
ND Eldeen et al. (2005) 
Menispermaceae      
Stephania suberosa Forman. Roots Methanol TLC and 96 well plate;  
91.93 ± 10.80 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Tiliacora triandra (Colebr.) 
Diel 
Root Methanol TLC and 96 well plate;  
42.29 ± 2.89 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Tinospora cordifolia Miers Stem Methanol 
 
TLC and 96 well plate;  
69.43 ± 0.37 (100 µg/ml) 
ND Vinutha et al. (2007) 
 Stem Aqueous TLC and 96 well plate;  
12.92 ± 0.26 (100 µg/ml) 
ND Vinutha et al. (2007) 
 
Mimosaceae      
Acacia nilotica (L.) Willd. ex 
Del. spp. kraussiana (Benth.) 
Brenan 
Leaf Ethyl acetate TLC and 96 well plate;  
53.00 ± 3.70 (1 mg/ml) 
ND Eldeen et al. (2005) 
 Leaf Ethanol TLC and 96 well plate;  
56.00 ± 6.30 (1 mg/ml) 
ND Eldeen et al. (2005) 
 
 
Bark Ethyl acetate TLC and 96 well plate;  
41.00 ± 2.10 (1 mg/ml) 
ND Eldeen et al. (2005) 
Acacia sieberiana Dc. var. 
woodii (Burtt Davy) Keay & 
Brenan 
Root Ethyl acetate TLC and 96 well plate;  
60.00 ± 4.30 (1 mg/ml) 
ND Eldeen et al. (2005) 
 Root Ethanol TLC and 96 well plate;  
62.00 ± 4.1 (1 mg/ml) 
ND Eldeen et al. (2005) 
Moraceae      
Ficus religiosa L. Bark Methanol TLC and 96 well plate;  
54.47 ± 1.28 (100 µg/ml) 
ND Vimutha et al. (2007) 
Streblus asper Lour. Seed Methanol TLC and 96 well plate;  
30.51 ± 4.21 (0.1 µg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
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Moringaceae      
Moringa oleifera Lam. Bark Methanol TLC and 96 well plate;  
4.99 ± 2.74 (100 µg/ml) 
ND Vinutha et al. (2007) 
Musaceae      
Musa sapientum L. Fruit Methanol TLC and 96 well plate;  
29.14 ± 4.73 (0.1 mg/ml)  
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Myristicaceae      
Myristica fragrans Houtt. Seed Hydroalcohol 96 well plate;  
50% (133.28 µg/ml)* 
ND Mukherjee et al. (2007 b) 
Myrsinaceae      
Embelia ribes Burm. f. Fruit Methanol TLC and 96 well plate;  
15.70 ± 1.19 (100 µg/ml) 
ND Vinutha et al. (2007) 
 
 Root Methanol TLC and 96 well plate;  
50.82 ± 0.71 (100 µg/ml) 
ND Vinutha et al. (2007) 
 
Nelumbonaceae      
Nelumbo nucifera Gaertn. Stamen Methanol TLC and 96 well plate;  
23.77 ± 2.83 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Nyctaginaceae      
Boerhavia diffusa L. Whole plant Methanol TLC and 96 well plate;  
23.78 ± 1.17 (100 µg/ml) 
ND Vinutha et al. (2007) 
 
Olacaceae      
Ptychopetalum olacoides 
Benth. 
Root Ethanol Dose dependent activity at doses 
of 50 and 100 mg/kg, i.p. 
ND Siqueira et al. (2003); 
Mukherjee et al. (2007 a) 
Papaveraceae      




Water TLC and 96 well plate;  
62.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
 Whole plant 
 
Methanol TLC and 96 well plate;  
85.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
 Tuber 
 
Water TLC and 96 well plate;  
92.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
 Tuber Methanol TLC and 96 well plate;  
92.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 




Water TLC and 96 well plate;  
57.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
 Whole plant 
 
Methanol TLC and 96 well plate;  
84.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
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 Tuber Water TLC and 96 well plate;  
78.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
 Tuber Methanol TLC and 96 well plate;  
97.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 




Water TLC and 96 well plate;  
78.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
 Whole plant 
 
Methanol TLC and 96 well plate;  
89.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
 Tuber Water TLC and 96 well plate;  
85.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
 Tuber Methanol TLC and 96 well plate;  
96.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 




Water TLC and 96 well plate;  
48.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
 Whole plant 
 
Methanol TLC and 96 well plate;  
82.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
 Tuber Water TLC and 96 well plate;  
87.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
 Tuber Methanol TLC and 96 well plate;  
97.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al. (2006) 
Piperaceae      
Piper interruptum Opiz Stems Methanol TLC and 96 well plate;  
65.16 ± 8.13 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Piper nigrum L. Seeds Methanol TLC and 96 well plate;  
58.02 ± 3.83 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Plumbaginaceae      
Plumbago indica L. Root Methanol TLC and 96 well plate;  
30.14 ± 3.28 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Poaceae      
Cymbopogon schoenanthus 
(L.) Spreng 
Whole plant Hexane 96 well plate;  
50% (0.55 mg/ml)* 
ND Khadri et al. (2010) 
 Whole plant Dichloromethane 96 well plate;  
50% (0.41 mg/ml)* 
ND Khadri et al. (2010) 
 Whole plant Ethyl acetate 96 well plate;  
50% (0.35 mg/ml)* 
ND Khadri et al. (2010) 
 Whole plant Methanol 96 well plate;  
50% (0.29 mg/ml)* 
ND Khadri et al. (2010) 
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 Whole plant Proanthocyanidin 96 well plate;  
50% (0.75 mg/ml)* 
ND Khadri et al. (2010) 
 Whole plant Aqueous 96 well plate;  
50% (0.42 mg/ml)* 
ND Khadri et al. (2010) 
Pyrolaceae      
Pyrola japonica Klenze ex 
Alefeld 
Whole plant Methanol 96 well plate;  
37.00 ± 2.00 (5 mg/ml) 
96 well plate; 
36.00 ± 3.00 (5 mg/ml) 
Sancheti et al. (2009) 
Rosaceae      
Sanguisorba minor Scop. Aerial parts 
 
Water UV spectophotometry; 
7.10 ± 1.60 (1 mg/ml)  
ND Ferreira et al. (2006) 
 
 Aerial parts Essential oil  UV spectophotometry; 
46.10 ± 9.70 (1 mg/ml)
 
ND Ferreira et al. (2006) 
 
 Aerial parts Ethanol UV spectophotometry; 
77.50 ± 2.20 (1 mg/ml)
 
ND Ferreira et al. (2006) 
 
Rubiaceae      
Paederia linearis Hook. f. 
 
Whole plant Methanol TLC and 96 well plate;  
29.31 ± 6.39 (0.1 mg/ml) 
ND Ingkaninan et al. 
(2003); Mukherjee et 
al. (2007 a) 
Rubia cordifolia L. Stem Methanol TLC and 96 well plate;  
22.12 ± 2.22 (100 µg/ml) 
ND Vinutha et al. (2007) 
 
 Stem Aqueous TLC and 96 well plate;  
5.86 ± 0.37 (100 µg/ml) 
ND Vinutha et al. (2007) 
 
Rutaceae      
Aegle marmelos (L.) Correa 
ex Roxb. 
Fruit pulp Methanol TLC and 96 well plate;  
44.65 ± 3.04 (0.1 mg/ml) 
ND Ingkaninan et al. 
(2003); Mukherjee et 
al. (2007 a) 
Ruta graveolens L. Whole plant Water TLC and 96 well plate;  
22.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al.(2006) 
 Whole plant Methanol TLC and 96 well plate;  
39.00 ± 0.00 (0.1 mg/ml) 
ND Adsersen et al.(2006) 
Sabiaceae      
Meliosma oldhamii Miq. ex. 
Maxim. 
Whole plant Methanol 96 well plate;  
12.00 ± 2.00 (5 mg/ml) 
96 well plate; 
19.00 ± 2.00 (5 mg/ml) 
Sancheti et al. (2009) 
Saliaceae      
Salix mucronata Thunb. Bark Ethyl acetate TLC and 96 well plate;  
82.00 ± 3.90 (1 mg/ml) 
ND Eldeen et al. (2005) 
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Sapotaceae      
Mimusops elengi L. Flower Methanol TLC and 96 well plate;  
32.81 ± 5.36 (0.1 mg/ml) 
ND Ingkaninan et al. (2003); 
Mukherjee et al. (2007 a) 
Scrophulariaceae      
Bacopa monniera L. Whole plant Ethanol 96 well plate;  
42.90 ± 1.20 (0.1 mg/ml) 
ND Das et al. (2002); 
Mukherjee et al. (2007 a) 
Solanaceae      
Withania somnifera Dunal. Root Methanol 
 
TLC and 96 well plate;  
75.95 ± 0.16 (100 µg/ml) 
ND Vinutha et al. (2007) 
 Root Aqueous TLC and 96 well plate;  
24.60 ± 0.38 (100 µg/ml) 
ND Vinutha et al. (2007) 
 
Symplocaceae      
Symplocos chinensis (Lour.) 
Druce 
Whole plant Methanol 
 
96 well plate;  
74.00 ± 2.00 (5 mg/ml) 
96 well plate; 
75.00 ± 2.00 (5 mg/ml) 
Sancheti et al. (2009) 
Tamariacaceae      
Myriacaria elegans Royle Aerial parts Methanol 96 well plate;  
74.80 ± 0.00 (0.2 µg/ml) 
ND Ahmad et al. (2003); 
Mukherjee et al. (2007 a) 
Umbelliferae      
Centella asiatica (L.) Urban Whole plant Hydroalcohol 96 well plate;  
50% (106.55 µg/ml)* 
ND Mukherjee et al. (2007 b) 
Valerianaceae      
Nardostachys jatamansi DC Rhizomes Methanol 96 well plate;  
50% (562.21 µg/ml)* 
ND Ahmed et al. (2009) 
Verbanaceae      
Lantana camara L. Aerial parts Aqueous TLC and 96 well plate;  
3.63 ± 1.20 (100 µg/ml) 
ND Vinutha et al. (2007) 
 
Zingiberaceae      
Alpinia galanga Willd. Rhizomes Methanol TLC and 96 well plate;  
16.98 ± 0.37 (100µg/ml) 
ND Vinuta et al. (2007) 
Zygophyllaceae      
Tribullus terrestris L. Whole plants Chloroform: methanol 
(1:1) 
96 well plate;  
37.89 ± 0.77 (1 mg/ml) 
96 well plate; 
78.32 ± 1.27 (1 mg/ml) 
Orhan et al. (2004) 
Zygophyllum fabago L. Whole plants Chloroform: methanol 
(1:1) 
96 well plate;  
13.25 ± 0.45 (1 mg/ml) 
96 well plate; 
78.37 ± 0.95 (1 mg/ml) 
Orhan et al. (2004) 
 
NI, no inhibition; ND, not done; * represents IC50 




acetylcholine, is considered one of the treatment 
strategies against several neurological disorders 
including AD. Several medicinal plants tested have been 
shown to have an inhibitory effect on AChE. Notable 
among such plants are several species belonging to the 
genus Corydalis (Adsersen et al., 2006). Kim et al. (1999) 
found that a methanolic extract of the tuber of Corydalis 
ternata showed significant inhibition of AChE. They 
isolated protopine, determined the IC50 value to be 50 µM 
and showed that mice treated with protopine exhibited 
diminished scopolamine-induced dementia measured in a 
passive avoidance task. Protopine has also been isolated 
from the tubers of Corydalis cava (Preininger et al., 
1976), and the aerial parts of Corydalis solida ssp. 
tauricola (Şener and Temizer, 1990). Berberine has been 
isolated from C. ternata and at 2.5 µM, this compound 
was found to have a reversible and specific AChE 
inhibitor effect (90%) (Hwang et al., 1996). It has been 
concluded that protoberberine- and protopine-type 
alkaloids, common compounds in Corydalis spp., are 
potent inhibitors of AChE (Adsersen et al. 2006). Plant 
species belonging to Fumariaceae, Papaveraceae and 
Ericaceae families have also been shown to have very 
strong activity against AChE and BChE. Since most of 
the acetylcholinesterase inhibitors are known to contain 
nitrogen, the strong activity of plants belonging to these 
families may be due to their rich alkaloid content (Orhan 
et al., 2004). Plant extracts having activities where 
percentage inhibition of the enzyme is 60% or more are 
considered to possess strong inhibitory activity (Khan et 
al., 2006), while moderate activity refers to percentage 
inhibition between 15 to 50% (Adsersen et al., 2006) and 
extracts having percentage inhibition of less than 15% do 
not show any significant inhibition of the enzyme. 
A large amount of evidence has demonstrated that 
oxidative stress is intimately involved in age-related 
neurodegenerative diseases and there have been a 
number of studies which have examined the positive 
benefits of antioxidants to reduce or to block neuronal 
death occurring in the pathophysiology of these disorders 
(Ramassamy, 2006; Loizzo et al., 2009).  
The anticholinesterase activities of 14 Salvia species 
were evaluated by Orhan et al. (2007). These plants were 
further screened for their antioxidant activity using the 
diphenyl picryl hydrazine (DPPH) and the xanthine 
oxidase (XO) inhibition assay. It was observed that the 
ethylacetate (EtOAc) extracts had high antioxidant 
activity against XO, ranging between 66.1% and 162.4%. 
The EtOAc and methanol (MeOH) extracts exhibited 
good DPPH radical-scavenging activity, similar to that of 
butylated hydroxyanisole (BHA), the reference drug used. 
Salvia species have been shown to contain phenolic 
compounds and its antioxidant activity has been ascribed 
to the presence of carnosic and rosmarinic acids 
(Cuvelier et al., 1996; Orhan et al., 2007). Salvianolic 
acid, a rosmarinic acid dimer isolated from Salvia 





activity for DPPH and superoxide anion radicals (Lu and 
Foo, 2001; Orhan et al., 2007). In addition, β-sitosterol 
isolated from Salvia plebeia was also found to be a 
strong antioxidant by the oxidative stability instrument 
(OSI) (Weng and Wang, 2000; Orhan et al., 2007). 
Several studies on the AChE inhibitory activity of some 
Salvia species have also been reported. The essential oil 
of Salvia lavandulaefolia, together with its major com-
ponents, α-pinene, 1,8-cineone, and camphor have been 
shown to have uncompetitive and reversible acetylcho-
linesterase inhibitory activity due to its monoterpenoids 
(Perry et al., 2000; Orhan et al., 2007). In another study, 
four diterpenes, dihydrotanshinone, cryptotanshinone, 
tanshinone I, and tanshinone IIA, were isolated from the 
acetone extract of the dried root of Salvia miltiorrhiza and 
it was concluded that these compounds contributed to the 
anticholinesterase activity of the plant (Ren et al., 2004; 
Orhan and Aslan, 2009). These data indicate that 
terpenoids and monoterpenes in Salvia species may be 
responsible for their anticholinesterase activity. Several 
other bioactive isolated compounds with cholinesterase 
inhibitory activity have been reported by Houghton et al. 
(2006) and Hostettmann et al. (2006). 
Khadri et al. (2010) evaluated the water, methanol and 
proanthocyanidin extracts of C. schoenanthus for its total 
phenolic content, total flavonoids and ability to scavenge 
the DPPH radical. The results obtained showed a high 
phenolic content in the three extracts with slightly higher 
values in the proanthocyanidinrich extracts. In addition, 
all the extracts were rich in flavonoids and they had very 
good antioxidant activity comparable to butylated hydro-
xytoluene (BHT), a known standard. The antioxidant 
activity of the plant together with its moderate inhibitory 
activity of acetylcholinesterase supports its medicinal use 
by local populations for treatment of neurodegenerative 
diseases. Antioxidant activity (DPPH and β-carotene-
linoleic acid assays), and acetylcholinesterase inhibitory 
activity were determined for 10 Portuguese plants (H. 
undulatum, M. officinalis, L. nobilis, L. pedunculata, S. 
minor, M. suaveolens, L. augustifolia, M. silvestris, P. 
argentea and S. officinalis) (Ferreira et al., 2006). The 
authors concluded that these plants may help in treating 
patients suffering from AD, as they showed inhibition of 
AChE and have very good antioxidant activity.  
Loizzo et al. (2009) further carried out studies on the 
antioxidant, and anti-inflammatory activities of the 
essential oils of O. ehrenbergii and O. syriacum to further 
validate their use in the treatment of AD. Both plants 
exhibited significant antioxidant activity and the chemical 
composition of O. syriacum essential oil indicated that it 
contained antioxidant compounds such as carvacrol, 
carvacrol methyl ether and thymol methyl ether (Mastelić 
et al., 2008; Loizzo et al., 2009). Inhibition of nitric oxide 
(NO) production may result in anti-inflammatory activity 
and this was studied in vitro by analyzing the effect of the 
essential oils on chemical mediators released from 





anti-inflammatory activity which is probably due to the 
presence of thymol, one of the major components of the 
oils which has a phenolic structure, and has been 
credited with a series of pharmacological properties, 
including antimicrobial, antioxidant and anti-inflammatory 
effects (Braga et al., 2006; Loizzo et al., 2009). These 
results showed that both oils provide interesting 
properties from a functional perspective in the prevention 
of neurodegenerative disorders. 
Chattipakorn et al. (2007) carried out additional in vivo 
studies on Tabernaemontana divaricata using male 
Wistar rats, after confirming its cholinesterase inhibitory 
activity in vitro. The major finding of this study was that 
the plant can inhibit neuronal AChE activity in an animal 
model and that it has cortical AChE inhibitory effects. 
According to the authors, there are several possible 
active compounds with AChE inhibitory activity in T. 
divaricata which include at least forty-four alkaloids and 
non-alkaloid constituents such as triterpenoids, steroids, 
flavonoids, phenyl propanoids and phenolic acids. The 
inhibitory effects of AChE activity in the animal model 
could be due to the effects of mixed alkaloids in T. 
divaricata. 
The 96-well microplate and thin layer chromatography 
assays based on Ellman’s method were the two most 
commonly used methods for detecting AChE and BChE 
inhibitory activity in the studies conducted. This is 
probably because these two methods ensure the 
possibility of running several replicates for each 
determination, to improve statistical treatment of results, 
and are both economical, as only small amounts of 
reagents and test substances are used. 
Methanol was observed to be the most commonly used 
solvent in extracting the plants. This may indicate that 
most of the compounds which show anticholinesterase 
activity are polar in nature. The plant part most commonly 
investigated was the aerial parts or whole plant (in case 
of herbs), indicating that roots or bark do not contain 





Present efforts aimed at the treatment of Alzheimer’s 
disease, senile dementia, ataxia, myasthenia gravis and 
Parkinson’s disease are centered around the reduction of 
cholinergic deficit by the use of AChE and BChE 
inhibitors. Several drugs are on the market, including the 
plant alkaloid galanthamine. However, a search for more 
efficient agents with fewer side effects has resulted in the 
screening of several medicinal plants for possible activity 
as shown in this review. It is easy to perceive the 
potential in these plants as attractive targets for future 
studies, to identify the active constituents and possibly to 
uncover new alternatives to the existing therapies for 
neurodegenerative diseases. Furthermore, in vivo activity 
of   the   active  compounds  needs  to  be  determined  in  




animal models and human subjects, so as to determine 
their efficacy in a metabolic environment. Such future 
studies will be necessary to expand the existing, limited 
therapeutic arsenal for the majority of neurodegenerative 
diseases, especially for those therapies with side effects 
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